Busheng Xue

7PUBLICATIONS
47CO-AUTHORS
Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 01, 2026
Site-specific methylation of SRSF2P95H by SETD2 inhibits MDSC-mediated proinflammatory niche formation in mouse models of myelodysplastic syndrome.

Zi-Juan Li, Mu-Ying Zhao, Roujia Wang

|Jul 02, 2025
Current Advances and Challenges in CAR-T Therapy for Hematological and Solid Tumors.

Gengtian Zhang, Mengyao Bai, Hanzhi Du

|Aug 26, 2023
Targeted Therapy for EWS-FLI1 in Ewing Sarcoma.

Helong Gong, Busheng Xue, Jinlong Ru

|Nov 26, 2022
T Cells Directed against the Metastatic Driver Chondromodulin-1 in Ewing Sarcoma: Comparative Engineering with CRISPR/Cas9 vs. Retroviral Gene Transfer for Adoptive Transfer.

Busheng Xue, Kristina von Heyking, Hendrik Gassmann

|Nov 27, 2021
Monocyte Maturation Mediators Upregulate CD83, ICAM-1 and MHC Class 1 Expression on Ewing's Sarcoma, Enhancing T Cell Cytotoxicity.

Emilie Biele, Sebastian J Schober, Carolin Prexler

|Aug 27, 2021
Ewing Sarcoma-Derived Extracellular Vesicles Impair Dendritic Cell Maturation and Function.

Hendrik Gassmann, Kira Schneider, Valentina Evdokimova

Pageof 2

Frequent Collaborators

2 joint publications

Sebastian J Schober

2 joint publications

Günther H S Richter

2 joint publications

Carolin Prexler

2 joint publications

Pengcheng He